Your session is about to expire
← Back to Search
Software-Aided Imaging for Liver Cancer Ablation
Study Summary
This trial is testing whether software-aided imaging can improve accuracy and effectiveness of liver ablation, compared to the current standard of visual inspection of CT scans.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am able to get out of my bed or chair and move around.My kidneys are functioning well.I do not have an active infection that could affect the study's safety or results.You have a physical or mental condition that would make it difficult for you to take part in the study.I haven't had treatments on the cancer spot within 30 days before the ablation.I have up to 3 liver tumors, each 1-3 cm, planned for a specific heat treatment.I have a blood clotting disorder that cannot be corrected.
- Group 1: Arm I (standard of care ablation)
- Group 2: Arm II (standard of care ablation, software-aided imaging)
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many individuals are being researched in this clinical trial?
"That is accurate, the clinical trial is currently underway. Per information available on clinicaltrials.gov, the first posting was made on 1/10/2020 with the most recent update being 8/25/2021. They are looking for 100 individuals total to participate at 1 location."
Is Ablation Therapy a high-risk treatment option?
"While Phase 2 trials offer less evidence than later stages in the development process, our team has assessed that there is enough data supporting the safety of ablation therapy to give it a score of 2."
Are there still open slots for volunteers in this research project?
"Yes, this is an active clinical trial that has been open since January 10th, 2020 and was last updated on August 25th, 2021 according to the information available on clinicaltrials.gov"
Share this study with friends
Copy Link
Messenger